Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3821-3830

  Cox, Michael E ^a   Deeble, Paul D ^a   Lakhani, Saquib ^a   Parsons, Sarah J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUCLADESINE; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; NEUROENDOCRINE TUMOR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; ADENOCARCINOMA; ANDROGENS; BIOLOGICAL MARKERS; BOMBESIN; BUCLADESINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CHROMOGRANIN A; CHROMOGRANINS; CYCLIC AMP; CYTOPLASMIC GRANULES; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; EPINEPHRINE; FORSKOLIN; HUMANS; ISOPROTERENOL; MALE; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; NEUROENDOCRINE TUMORS; NEUROTENSIN; PARATHYROID HORMONE-RELATED PROTEIN; PHENOTYPE; PHOSPHOPYRUVATE HYDRATASE; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTEINS; SECOND MESSENGER SYSTEMS; SEROTONIN; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0033178914     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. di Sant'Agnese, P. A. Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol., 23: 287-296, 1992.
2. Abrahamsson, P. A., and Lilja, H. Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland. Prostate, 14: 71-81, 1989.
3. Seuwen, K., and Pouyssegur, J. Serotonin as a growth factor. Biochem. Pharmacol., 39: 985-990, 1990.
4. Willey, J. C., Lechner, J. F., and Harris, C. C. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp. Cell Res., 153: 245-248, 1984.
5. Dalsgaard, C. J., Hultgardh-Nilsson, A., Haegerstrand, A., and Nilsson, J. Neuropeptides as growth factors. Possible roles in human diseases. Regul. Pept., 25: 1-9, 1989.
6. Iwamura, M., Abrahamsson, P. A., Foss, K. A., Wu, G., Cockett, A. T., and Deftos, L. J. Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology, 43: 675-679, 1994.
7. Gkonos, P. J., Krongrad, A., and Roos, B. A. Neuroendocrine peptides in the prostate. Urol. Res., 23: 81-87, 1995.
8. Bonkhoff, H., and Remberger, K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98-106, 1996.
9. Aprikian, A. G., Cordon-Cardo, C., Fair, W. R., and Reuter, V. E. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer (Phila.), 71: 3952-3965, 1993.
10. Bonkhoff, H., Stein, U., and Remberger, K. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum. Pathol., 25: 42-46, 1994.
11. Abrahamsson, P. A., and di Sant'Agnese, P. A. Neuroendocrine cells in the human prostate gland. J. Androl., 14: 307-309, 1993.
12. Nakada, S. Y., di Sant'Agnese, P. A., Moynes, R. A., Hiipakka, R. A., Liao, S., Cockett, A. T., and Abrahamsson, P. A. The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Cancer Res., 53: 1967-1970, 1993.
13. di Sant'Agnese, P. A., and Cockett, A. T. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research. J. Urol., 152: 1927-1931, 1994.
14. di Sant'Agnese, P. A., and de Mesy Jensen, K. L. Neuroendocrine differentiation in prostatic carcinoma. Hum. Pathol., 18: 849-856, 1987.
15. Oesterling, J. E., Hauzeur, C. G., and Farrow, G. M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J. Urol., 147: 804-807, 1992.
16. Sarma, D. P., and Weilbaecher, T. G. Small-cell carcinoma of prostate. Urology, 33: 332-335, 1989.
17. Cohen, R. J., Glezerson, G., and Haffejee, Z. Neuro-endocrine cells: a new prognostic parameter in prostate cancer. Br. J. Urol., 68: 258-262, 1991.
18. Weinstein, M. H., Partin, A. W., Veltri, R. W., and Epstein, J. I. Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum. Pathol., 27: 683-687, 1996.
19. Dauge, M. C., and Delmas, V. A. P. U. D. type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma. Prog. Clin. Biol. Res., 243A: 529-531, 1987.
20. Tarle, M., Frkovic-Grazio, S., Kraljic, I., and Kovacic, K. A more objective staging of advanced prostate cancer-routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values. Prostate, 24: 143-148, 1994.
21. Casamento, J., Abrahamsson, P. A., Nakada, S. Y., di Sant'Agnese, P. A., de Mesy Jensen, K., and Cockett, A. T. Prognostic significance of neuroendocrine differentiation in prostate carcinoma. J. Urol., 147: 479-479, 1992.
22. Noordzij, M. A., van der Kwast, T. H., van Steenbrugge, G. J., Hop, W. J., and Schroder, F. H. The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy. Int. J. Cancer, 62: 252-258, 1995.
23. Theodorescu, R., Broder, S. R., Boyd, J. C., Mills, S. E., and Frierson, H. F. Cathepsin D And chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer (Phila.), 80: 2109-2119, 1997.
24. Bonkhoff, H., Wernert, N., Dhom, G., and Remberger, K. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate, 19: 91-98, 1991.
25. Bonkhoff, H., Stein, U., and Remberger, K. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum. Pathol., 26: 167-170, 1995.
26. Bang, Y. J., Pirnia, F., Fang, W. G., Kang, W. K., Sartor, O., Whitesell, L., Ha, M. J., Tsokos, M., Sheahan, M. D., and Nguyen, P. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. Natl. Acad. Sci. USA, 91: 5330-5334, 1994.
27. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
28. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer (published erratum appears in Cancer Res., 54: 3953, 1994). Cancer Res., 54: 2577-2581, 1994.
29. Bushman, W. A., Wilson, L. K., Luttrell, D. K., Moyers, J. S., and Parsons, S. J. Overexpression of c-src enhances β-adrenergic-induced cAMP accumulation. Proc. Natl. Acad. Sci. USA, 87: 7462-7466, 1990.
30. Harper, J. F., and Brooker, G. Femptomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′Oacetylation by acetic anhydride in aqueous solution. J. Cyclic Nucleotide Res., 1: 207-218, 1975.
31. Venable, J. H., and Coggeshall, R. A. A simplified lead citrate stain for use in electron microscopy. J. Cell Biol., 25: 407-408, 1965.
32. Lee, C., Sutkowski, D. M., Sensibar, J. A., Zelner, D., Kim, I., Amsel, I., Shaw, N., Prins, G. S., and Kozlowski, J. M. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology, 136: 796-803, 1995.
33. Ely, C. M., Oddie, K. M., Litz, J. S., Rossomando, A. J., Kanner, S. B., Sturgill, T. W., and Parsons, S. J. A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts. J. Cell Biol., 110: 731-142, 1990.
34. Reuter, C. W., Catling, A. D., and Weber, M. J. Immune complex kinase assays for mitogen-activated protein kinase and MEK. Methods Enzymol., 255: 245-256, 1995.
35. Ray, L. B., and Sturgill, T. W. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. USA, 84: 1502-1506, 1987.
36. Huang, R. D., Smith, M. F., and Zahler, W. L. Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. J. Cyclic Nucleotide Res., 8: 385-394, 1982.
37. O'Connor, D. T., Wu, H., Gill, B. M., Rozansky, D. J., Tang, K., Mahata, S. K., Eskeland, N. L., Videen, J. S., and Zhang, X. Hormone storage vesicle proteins. Transcriptional basis of the widespread neuroendocrine expression of chromogranin A, and evidence of its diverse biological actions, intracellular and extracellular. Ann. N. Y. Acad. Sci., 733: 36-45, 1994.
38. di Sant'Agnese, P. A., and de Mesy Jensen, K. L. Endocrine-paracrine cells of the prostate and prostatic urethra: an ultrastructural study. Hum. Pathol., 15: 1034-1041, 1984.
39. Diaz, M., Abdul, M., and Hoosein, N. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2. Prostate (Suppl.), 8: 32-36, 1998.
40. Iwamura, M., Wu, G., Abrahamsson, P. A., di Sant'Agnese, P. A., Cookett, A. T., and Deftos, L. J. Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells. Urology, 43: 667-674, 1994.
41. Seethalakshmi, L., Mitra, S. P., Dobner, P. R., Menon, M., and Carraway, R. E. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate, 31: 183-192, 1997.
42. Sehgal, I., Powers, S., Huntley, B., Powis, G., Pittelkow, M., and Maihle, N. J., Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc. Natl. Acad. Sci. USA, 91: 4673-4677, 1994.
43. 2+ transients. Endocrinology, 134: 596-602, 1994.
44. di Sant'Agnese, P. A. Calcitonin-like immunoreactive and bombesin-like immunoreactive endocrine-paracrine cells of the human prostate. Arch. Pathol. Lab. Med., 110: 412-415, 1986.
45. Pinski, J., Schally, A. V., Halmos, G., and Szepeshazi, K. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Int. J. Cancer, 55: 963-967, 1993.
46. Pinski, J., Reile, H., Halmos, G., Groot, K., and Schally, A. V. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Cancer Res., 54: 169-174, 1994.
47. Tarle, M., and Rados, N. Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay. Prostate, 19: 23-33, 1991.
48. Kadmon, D., Thompson, T. C., Lynch, G. R., and Scardino, P. T. Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J. Urol., 146: 358-361, 1991.
49. Bonkhoff, H. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate (Suppl.), 8: 18-22, 1998.
50. Hsieh, T. C., Xu, W., and Chiao, J. W. Growth regulation and cellular changes during differentiation of human prostatic cancer LNCaP cells as induced by T lymphocyte-conditioned medium. Exp. Cell Res., 218: 137-143, 1995.
51. Qiu, Y., Robinson, D., Pretlow, T. G., and Kung, H. J. Etk/Bmx, a tyrosine kinase with pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA, 95: 3644-3649, 1998.
52. Shen, R., Dorai, T., Szaboles, M., Katz, A. E., Olsson, C. A., and Buttyan, R. Transdifferentiation of cultured human prostate cells to a neuroendocrine cell phenotype in a hormone-depleted medium. Urol. Res., 5: 67-75, 1997.